90 related articles for article (PubMed ID: 7060630)
1. Dopamine autoreceptors differ pharmacologically from postsynaptic dopamine receptors: effects of (-)-N-(2-chloroethyl)-norapomorphine.
Lehmann J; Langer SZ
Eur J Pharmacol; 1982 Jan; 77(1):85-6. PubMed ID: 7060630
[No Abstract] [Full Text] [Related]
2. Dopamine receptors modulating [3H]acetylcholine release in slices of the cat caudate: effects of (-)-N-(2-chloroethyl)-norapomorphine.
Lehmann J; Lee CR; Langer SZ
Eur J Pharmacol; 1983 Jun; 90(4):393-400. PubMed ID: 6884428
[TBL] [Abstract][Full Text] [Related]
3. The effects of (-)N-(chloroethyl)-norapomorphine on [3H]-apomorphine binding to striatal dopamine receptors.
Goosey MW; Doggett NS
Biochem Pharmacol; 1982 Nov; 31(22):3693-4. PubMed ID: 7181954
[No Abstract] [Full Text] [Related]
4. The dopamine-sensitive adenylate cyclase of the rat caudate nucleus--3. The effect of aporphines and protoberberines.
Sheppard H; Brughardt CR
Biochem Pharmacol; 1978; 27(8):1113-6. PubMed ID: 697912
[No Abstract] [Full Text] [Related]
5. Aporphines. 30. (-)-N(2-chloroethyl)-10,11-dihydroxynor-aporphine (chloroethylnorapomorphine), a novel irreversible dopamine receptor antagonist.
Neumeyer JL; Law SJ; Baldessarini RJ; Kula NS
J Med Chem; 1980 Jun; 23(6):594-5. PubMed ID: 7392026
[No Abstract] [Full Text] [Related]
6. On the ability of N-chloroethyl aporphine derivatives to cause irreversible inhibition of dopamine receptor mechanisms.
Costall B; Fortune DH; Granchelli FE; Law SJ; Naylor RJ; Neumeyer JL; Nohria V
J Pharm Pharmacol; 1980 Aug; 32(8):571-6. PubMed ID: 6106696
[No Abstract] [Full Text] [Related]
7. Decreased sensitivity of caudatal neurons to microiontophoretic dopamine in dopamine-depleted caudate nucleus.
Norcross K; Spehlmann R
Brain Res; 1978 Nov; 156(1):175-80. PubMed ID: 698832
[No Abstract] [Full Text] [Related]
8. Dissociation between behavioral effects of (-)-N-(2-chloroethyl)-norapomorphine and D2 dopamine receptor-like activity.
Helmeste DM
Eur J Pharmacol; 1983 Nov; 95(3-4):277-81. PubMed ID: 6317413
[TBL] [Abstract][Full Text] [Related]
9. Stereoisomers of apomorphine differ in affinity and intrinsic activity at presynaptic dopamine receptors modulating [3H]dopamine and [3H]acetylcholine release in slices of cat caudate.
Lehmann J; Smith RV; Langer SZ
Eur J Pharmacol; 1983 Mar; 88(1):81-8. PubMed ID: 6852106
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of [3H]apomorphine binding to bovine brain tissue.
Arana GW; Baldessarini RJ; Harding M
Biochem Pharmacol; 1981 Dec; 30(23):3171-9. PubMed ID: 7317102
[No Abstract] [Full Text] [Related]
11. A quantitative analysis of the excitatory and depressant effects of dopamine on the firing of caudatal neurons: electrophysiological support for the existence of two distinct dopamine-sensitive receptors.
Norcross K; Spehlmann R
Brain Res; 1978 Nov; 156(1):168-74. PubMed ID: 698831
[No Abstract] [Full Text] [Related]
12. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
Lehmann J; Briley M; Langer SZ
Eur J Pharmacol; 1983 Mar; 88(1):11-26. PubMed ID: 6133762
[TBL] [Abstract][Full Text] [Related]
13. Rapid desensitization of presynaptic dopamine autoreceptors during exposure to exogenous dopamine.
Arbilla S; Nowak JZ; Langer SZ
Brain Res; 1985 Jun; 337(1):11-7. PubMed ID: 4005600
[TBL] [Abstract][Full Text] [Related]
14. Essential fatty acids modulate apomorphine activity at dopamine receptors in cat caudate slices.
Davidson B; Kurstjens NP; Patton J; Cantrill RC
Eur J Pharmacol; 1988 May; 149(3):317-22. PubMed ID: 2900769
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D4 receptors bind inactive (+)-aporphines, suggesting neuroleptic role. Sulpiride not stereoselective.
Seeman P; Van Tol HH
Eur J Pharmacol; 1993 Mar; 233(1):173-4. PubMed ID: 8097160
[TBL] [Abstract][Full Text] [Related]
16. Chloroethylnorapomorphine, a proposed long-acting dopamine antagonist: interactions with dopamine receptors of mammalian forebrain in vitro.
Baldessarini RJ; Kula NS; Arana GW; Neumeyer JL; Law SJ
Eur J Pharmacol; 1980 Oct; 67(1):105-10. PubMed ID: 7418727
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic modulation of the release of dopamine from the rabbit caudate nucleus: differences between electrical stimulation, amphetamine and tyramine.
Kamal LA; Arbilla S; Langer SZ
J Pharmacol Exp Ther; 1981 Mar; 216(3):592-8. PubMed ID: 6259324
[No Abstract] [Full Text] [Related]
18. Aporphines. 50. Kinetics of solvolysis of N-(2-chloroethyl)norapomorphine, an irreversible dopamine receptor antagonist.
Cohen SA; Neumeyer JL
J Med Chem; 1983 Oct; 26(10):1348-53. PubMed ID: 6620296
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous demonstration of the activation of presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in vitro by N,N-dipropyl-5,6-ADTN.
Stoof JC; Horn AS; Mulder AH
Brain Res; 1980 Aug; 196(1):276-81. PubMed ID: 7397528
[No Abstract] [Full Text] [Related]
20. Dopamine autoreceptors modulate the in vivo release of dopamine in the frontal, cingulate and entorhinal cortices.
Altar CA; Boyar WC; Oei E; Wood PL
J Pharmacol Exp Ther; 1987 Jul; 242(1):115-20. PubMed ID: 3612520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
